These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15123238)

  • 1. The first fluorescent diboronic acid sensor specific for hepatocellular carcinoma cells expressing sialyl Lewis X.
    Yang W; Fan H; Gao X; Gao S; Karnati VV; Ni W; Hooks WB; Carson J; Weston B; Wang B
    Chem Biol; 2004 Apr; 11(4):439-48. PubMed ID: 15123238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diboronic acids as fluorescent probes for cells expressing sialyl Lewis X.
    Yang W; Gao S; Gao X; Karnati VV; Ni W; Wang B; Hooks WB; Carson J; Weston B
    Bioorg Med Chem Lett; 2002 Aug; 12(16):2175-7. PubMed ID: 12127531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Water-soluble fluorescent boronic acid compounds for saccharide sensing: substituent effects on their fluorescence properties.
    Zhang Y; Gao X; Hardcastle K; Wang B
    Chemistry; 2006 Feb; 12(5):1377-84. PubMed ID: 16294348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TIP30 mutant derived from hepatocellular carcinoma specimens promotes growth of HepG2 cells through up-regulation of N-cadherin.
    Jiang C; Pecha J; Hoshino I; Ankrapp D; Xiao H
    Cancer Res; 2007 Apr; 67(8):3574-82. PubMed ID: 17440068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of sialyl Lewis(x) in hepatocellular carcinoma.
    Tori A; Harada A; Nakao A; Nonami T; Ito M; Takagi H
    Hepatogastroenterology; 1995; 42(6):939-43. PubMed ID: 8847049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenovirus vector expressing mda-7 selectively kills hepatocellular carcinoma cell line Hep3B.
    Xue XB; Chen K; Wang CJ; Zheng JW; Yu Y; Peng ZH; Wu ZD
    Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):509-14. PubMed ID: 18842498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A fluorescent bisboronic acid compound that selectively labels cells expressing oligosaccharide Lewis X.
    Gao X; Zhu M; Fan H; Yang W; Ni W; Karnati VV; Gao S; Carson J; Weston B; Wang B
    Bioorg Med Chem Lett; 2015 Jun; 25(12):2501-4. PubMed ID: 25956415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, evaluation, and computational studies of naphthalimide-based long-wavelength fluorescent boronic Acid reporters.
    Jin S; Wang J; Li M; Wang B
    Chemistry; 2008; 14(9):2795-804. PubMed ID: 18228545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A high expression of GDP-fucose transporter in hepatocellular carcinoma is a key factor for increases in fucosylation.
    Moriwaki K; Noda K; Nakagawa T; Asahi M; Yoshihara H; Taniguchi N; Hayashi N; Miyoshi E
    Glycobiology; 2007 Dec; 17(12):1311-20. PubMed ID: 17884843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.
    Xue WJ; Li C; Zhou XJ; Guan HG; Qin L; Li P; Wang ZW; Qian HX
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1448-58. PubMed ID: 17683489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New boronic acid fluorescent reporter compounds. 2. A naphthalene-based on-off sensor functional at physiological pH.
    Gao X; Zhang Y; Wang B
    Org Lett; 2003 Nov; 5(24):4615-8. PubMed ID: 14627397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significant decrease in alpha1,3-linked fucose in association with increase in 6-sulfated N-acetylglucosamine in peripheral lymph node addressin of FucT-VII-deficient mice exhibiting diminished lymphocyte homing.
    Hiraoka N; Petryniak B; Kawashima H; Mitoma J; Akama TO; Fukuda MN; Lowe JB; Fukuda M
    Glycobiology; 2007 Mar; 17(3):277-93. PubMed ID: 17172261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A sequential treatment of depsipeptide followed by 5-azacytidine enhances Gadd45beta expression in hepatocellular carcinoma cells.
    Jiang C; Zhou B; Fan K; Heung E; Xue L; Liu X; Kirschbaum M; Yen Y
    Anticancer Res; 2007; 27(6B):3783-9. PubMed ID: 18225533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bortezomib arrests the proliferation of hepatocellular carcinoma cells HepG2 and JHH6 by differentially affecting E2F1, p21 and p27 levels.
    Baiz D; Pozzato G; Dapas B; Farra R; Scaggiante B; Grassi M; Uxa L; Giansante C; Zennaro C; Guarnieri G; Grassi G
    Biochimie; 2009 Mar; 91(3):373-82. PubMed ID: 19041685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Differential display of messenger RNA and identification of selenocysteine lyase gene in hepatocellular carcinoma cells transiently expressing hepatitis C virus core protein].
    Yepes JO; Luz Gunturiz M; Henao LF; Navas MC; Balcázar N; Gómez LA
    Biomedica; 2006 Jun; 26(2):194-205. PubMed ID: 16925092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhibitory effect of blocking expression of human augmenter of liver regeneration (hALR) on proliferation of hepatocellular carcinoma cell line HepG2].
    Tang L; Sun H; Zhang L; Guo H; Zhang L; Liu Q
    Ai Zheng; 2006 Jun; 25(6):671-6. PubMed ID: 16764759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective down-regulation of glioma-associated oncogene 2 inhibits the proliferation of hepatocellular carcinoma cells.
    Kim Y; Yoon JW; Xiao X; Dean NM; Monia BP; Marcusson EG
    Cancer Res; 2007 Apr; 67(8):3583-93. PubMed ID: 17440069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of NET-1 gene expression with human hepatocellular carcinoma.
    Chen L; Wang Z; Zhan X; Li DC; Zhu YY; Zhu J
    Int J Surg Pathol; 2007 Oct; 15(4):346-53. PubMed ID: 17913940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of tumor-associated antigens by using SEREX in hepatocellular carcinoma.
    Wang K; Xu X; Nie Y; Dai L; Wang P; Zhang J
    Cancer Lett; 2009 Aug; 281(2):144-50. PubMed ID: 19304375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in the expression of sialyl-Lewisx, a hepatic necroinflammation-associated carbohydrate neoantigen, in human hepatocellular carcinomas.
    Okada Y; Jin-no K; Ikeda H; Sakai N; Sotozono M; Yonei T; Nakanishi S; Moriwaki S; Tsuji T
    Cancer; 1994 Apr; 73(7):1811-6. PubMed ID: 7907941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.